Clinical Trial Update: Safety, Tolerability, and Efficacy of GS-9876 in Participants With Active Rheumatoid Arthritis on Background Therapy With Methotrexate [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating safety, tolerability, and efficacy of GS-9876 in active rheumatoid arthritis patients on methotrexate.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• GS-9876

Snippet

Sponsor: Gilead Sciences | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2018-09-19